Biogen stock opened higher on positive lupus readout Investing.com Biogen stock opened higher on positive lupus readout. Biogen (BIIB) 4 hours
Biogen and Belgian partner UCB announce positive data from late-stage trial of lupus treatment MarketWatch 4 hours
Biogen Inc.’s (BIIB) Morgan Stanley’s 22nd Annual Global Healthcare Conference Transcript Seeking Alpha 3 weeks
Biogen Stock Slips As Alzheimer’s Drug Looks Abroad For Quarterly Beat Investor's Business Daily 2 months
Biogen beats expectations, hikes outlook as Alzheimer’s drug and other new products gain traction CNBC 2 months
Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer’s Drug Investor's Business Daily 2 months
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical Zacks 2 months
Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails Investor's Business Daily 2 months
Ionis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong Investor's Business Daily 2 months
Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer’s Drug Investor's Business Daily 3 months
FDA Panelists Unanimously Back Eli Lilly’s Biogen-Rivaling Alzheimer’s Drug Investor's Business Daily 4 months
Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront MarketWatch 4 months
Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer’s Treatment Investor's Business Daily 4 months
Biotech Stock Roundup: BIIB, BMY’s Q1 Earnings, INCY’s Acquisition & Updates from VRTX Zacks 5 months
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations Investor's Business Daily 5 months
Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves MarketWatch 5 months